These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
255 related items for PubMed ID: 26121434
21. Postoperative persistent thyrotrophin releasing hormone-induced growth hormone release predicts recurrence in patients with acromegaly. Biermasz NR, Smit JW, van Dulken H, Roelfsema F. Clin Endocrinol (Oxf); 2002 Mar; 56(3):313-9. PubMed ID: 11940042 [Abstract] [Full Text] [Related]
22. Long-term endocrinological outcomes of gamma knife radiosurgery in acromegaly patients. Uygur MM, Deyneli O, Yavuz DG. Growth Horm IGF Res; 2020 Dec; 55():101335. PubMed ID: 33190108 [Abstract] [Full Text] [Related]
23. Radiosurgery of growth hormone-producing pituitary adenomas: factors associated with biochemical remission. Pollock BE, Jacob JT, Brown PD, Nippoldt TB. J Neurosurg; 2007 May; 106(5):833-8. PubMed ID: 17542527 [Abstract] [Full Text] [Related]
24. Changing patterns of insulin-like growth factor-I and glucose-suppressed growth hormone levels after pituitary surgery in patients with acromegaly. Espinosa-de-los-Monteros AL, Mercado M, Sosa E, Lizama O, Guinto G, Lopez-Felix B, Garcia O, Hernández I, Ovalle A, Mendoza V. J Neurosurg; 2002 Aug; 97(2):287-92. PubMed ID: 12186455 [Abstract] [Full Text] [Related]
25. Predictors of postoperative biochemical remission in lower Knosp grade growth hormone-secreting pituitary adenomas: a large single center study. Zhang S, Chen J, Yao S, Akter F, Wang Z, Hu B, Zhu D, Duan C, Chen W, Zhu Y, Wang H, Mao Z. J Endocrinol Invest; 2023 Mar; 46(3):465-476. PubMed ID: 36125731 [Abstract] [Full Text] [Related]
26. Transsphenoidal surgery for acromegaly: endocrinological follow-up of 98 patients. Shimon I, Cohen ZR, Ram Z, Hadani M. Neurosurgery; 2001 Jun; 48(6):1239-43; discussion 1244-5. PubMed ID: 11383725 [Abstract] [Full Text] [Related]
28. Evolving criteria for post-operative biochemical remission of acromegaly: can we achieve a definitive cure? An audit of surgical results on a large series and a review of the literature. Minniti G, Jaffrain-Rea ML, Esposito V, Santoro A, Tamburrano G, Cantore G. Endocr Relat Cancer; 2003 Dec; 10(4):611-9. PubMed ID: 14713271 [Abstract] [Full Text] [Related]
29. The common consensus criteria have high predictive values for long-term postoperative acromegaly remission. Kristof RA, Grote A, Redel L, Neuloh G, Klingmüller D, Schramm J. Acta Neurochir (Wien); 2011 Jan; 153(1):19-25. PubMed ID: 20845050 [Abstract] [Full Text] [Related]
30. Acromegaly. Scacchi M, Cavagnini F. Pituitary; 2006 Jan; 9(4):297-303. PubMed ID: 17077948 [Abstract] [Full Text] [Related]
31. Prognostic factors of biochemical remission after transsphenoidal surgery for acromegaly: a structured review. Agrawal N, Ioachimescu AG. Pituitary; 2020 Oct; 23(5):582-594. PubMed ID: 32602066 [Abstract] [Full Text] [Related]
32. Caloric restriction as a possible pitfall for persistent acromegaly follow-up - case report. Martins AF, Santos M, Rosário F. BMC Endocr Disord; 2023 Mar 27; 23(1):68. PubMed ID: 36973824 [Abstract] [Full Text] [Related]
33. Correlation analysis between short-term insulin-like growth factor-I and glucose intolerance status after transsphenoidal adenomectomy in acromegalic patients: a large retrospective study from a single center in China. Li YL, Zhang S, Guo XP, Gao L, Lian W, Yao Y, Deng K, Wang RZ, Xing B. Arch Endocrinol Metab; 2019 Mar 27; 63(2):157-166. PubMed ID: 30916168 [Abstract] [Full Text] [Related]
34. Surgical and Pharmacological Outcomes in Acromegaly: Real-Life Data From the Mexican Acromegaly Registry. Mercado M, Abreu C, Vergara-López A, González-Virla B, Espinosa-de-Los-Monteros AL, Sosa-Eroza E, Cadena-Obando D, Cuevas-Ramos D, Portocarrero-Ortiz LA, Pérez-Reyes SP, Mercado-Cherem A, Ibarra-Salce R, Talavera JO. J Clin Endocrinol Metab; 2020 Dec 01; 105(12):. PubMed ID: 32944780 [Abstract] [Full Text] [Related]
35. Ten-year follow-up results of transsphenoidal microsurgery in acromegaly. Biermasz NR, van Dulken H, Roelfsema F. J Clin Endocrinol Metab; 2000 Dec 01; 85(12):4596-602. PubMed ID: 11134114 [Abstract] [Full Text] [Related]
36. Value of Early Post-Operative Growth Hormone Testing in Predicting Long-Term Remission and Residual Disease after Transsphenoidal Surgery for Acromegaly. Wang YY, Waqar M, Abou-Zeid A, Kearney T, Caputo C, Davis J, Trainer P, Higham C, Roncaroli F, Gnanalingham KK. Neuroendocrinology; 2022 Dec 01; 112(4):345-357. PubMed ID: 34052822 [Abstract] [Full Text] [Related]
37. Forty month follow-up of persistent and difficultly controlled acromegalic patients treated with depot long acting somatostatin analog octreotide. Yetkin DO, Boysan SN, Tiryakioglu O, Yalin AS, Kadioglu P. Endocr J; 2007 Jun 01; 54(3):459-64. PubMed ID: 17495423 [Abstract] [Full Text] [Related]
38. Long-term control of acromegaly after pituitary surgery in South-Eastern Norway. Falch CM, Dupont AK, Olarescu NC, Wiedmann M, Dahlberg D, Bollerslev J, Berg-Johnsen J, Heck A. Acta Neurochir (Wien); 2023 Oct 01; 165(10):3003-3010. PubMed ID: 37665404 [Abstract] [Full Text] [Related]
39. Clinical, hormonal and magnetic resonance imaging (MRI) predictors of transsphenoidal surgery outcome in acromegaly. Bourdelot A, Coste J, Hazebroucq V, Gaillard S, Cazabat L, Bertagna X, Bertherat J. Eur J Endocrinol; 2004 Jun 01; 150(6):763-71. PubMed ID: 15191345 [Abstract] [Full Text] [Related]
40. Delayed Remission of Growth Hormone-Secreting Pituitary Adenoma After Transsphenoidal Adenectomy. Wang Z, Guo X, Gao L, Feng C, Lian W, Deng K, Bao X, Feng M, Wang R, Xing B. World Neurosurg; 2019 Feb 01; 122():e1137-e1145. PubMed ID: 30447463 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]